Acoziborole
Acoziborole (SCYX-7158) is a novel benzoxaborole derivative developed as an oral treatment for human African trypanosomiasis. It demonstrates potent in vitro activity against Trypanosoma brucei, with an MIC of 0.6 μg/mL for the S427 strain, and has shown promising efficacy in advanced preclinical and clinical studies.
Product Specifications
CAS Number
1266084-51-8
Field of Research
Infectious Disease & Virology
Smiles
CC1 (C) OB (O) C2=CC (NC (=O) C3=CC=C (F) C=C3C (F) (F) F) =CC=C12
Molecular Formula
C17H14BF4NO3
Molecular Weight
367.1
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6579307 1.0 µg DNA
Vps72 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details 
E1664Hu-01 48 Well
Human colon cancer-specific antigen-4, CCSA-4 ELISA KIT
Sign In for Pricing
View Details E1664Hu-02 96 Well
Human colon cancer-specific antigen-4, CCSA-4 ELISA KIT
Sign In for Pricing
View Details E1664Hu-03 5x 96 Tests
Human colon cancer-specific antigen-4, CCSA-4 ELISA KIT
Sign In for Pricing
View Details